TBWA
Three Bridge Wealth Advisors Portfolio holdings
AUM
$380M
This Quarter Return
+12.28%
1 Year Return
+30.39%
3 Year Return
+178.18%
5 Year Return
–
10 Year Return
–
AUM
$216M
AUM Growth
+$216M
(+16%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
5.14%
Top 10 Holdings %
Top 10 Hldgs %
59.01%
Holding
94
New
12
Increased
40
Reduced
21
Closed
2
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$1.48M |
| 2 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$1.01M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$1M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$982K |
| 5 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$801K |
Top Sells
| 1 |
Affirm
AFRM
|
$2.14M |
| 2 |
Novo Nordisk
NVO
|
$593K |
| 3 |
Oracle
ORCL
|
$588K |
| 4 |
Coinbase
COIN
|
$527K |
| 5 |
Charles Schwab
SCHW
|
$278K |
Sector Composition
| 1 | Technology | 21.65% |
| 2 | Financials | 6.41% |
| 3 | Healthcare | 3.49% |
| 4 | Communication Services | 3.22% |
| 5 | Consumer Discretionary | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DocuSign
DOCU
$15B
| $1.71M | 0.79% |
29,382
| – | – |
|
27
Invesco FTSE RAFI US 1000 ETF
PRF
$8.04B
| $1.71M | 0.79% |
10,923
+223
| +2% | +$35K |
|
28
Unilever
UL
$156B
| $1.6M | 0.74% |
30,856
+9,362
| +44% | +$486K |
|
29
Home Depot
HD
$404B
| $1.52M | 0.7% |
5,135
+396
| +8% | +$117K |
|
|
30
Novo Nordisk
NVO
$251B
| $1.47M | 0.68% |
9,152
-3,697
| -29% | -$593K |
|
31
Nike
NKE
$110B
| $1.46M | 0.68% |
11,869
-190
| -2% | -$23.4K |
|
32
Starbucks
SBUX
$102B
| $1.36M | 0.63% |
13,098
+840
| +7% | +$87.5K |
|
33
iShares MSCI EAFE ETF
EFA
$65.3B
| $1.35M | 0.63% |
18,900
| – | – |
|
34
Medtronic
MDT
$120B
| $1.27M | 0.59% |
15,571
+6,023
| +63% | +$490K |
|
35
General Dynamics
GD
$87.3B
| $1.18M | 0.55% |
5,185
-63
| -1% | -$14.4K |
|
36
C.H. Robinson
CHRW
$15.2B
| $1.18M | 0.55% |
11,804
+193
| +2% | +$19.3K |
|
37
Adobe
ADBE
$147B
| $1.17M | 0.54% |
3,048
+1,193
| +64% | +$460K |
|
38
Visa
V
$679B
| $1.14M | 0.53% |
5,059
+1,536
| +44% | +$346K |
|
39
Accenture
ACN
$160B
| $1.13M | 0.52% |
3,955
+568
| +17% | +$162K |
|
40
Ginkgo Bioworks
DNA
$652M
| $1.11M | 0.51% |
833,802
| – | – |
|
41
Johnson & Johnson
JNJ
$429B
| $1.09M | 0.51% |
7,064
+2,423
| +52% | +$376K |
|
|
42
SPDR Portfolio S&P 500 Growth ETF
SPYG
$40B
| $1.01M | 0.47% |
+18,200
| New | +$1.01M |
|
43
Biogen
BIIB
$20.5B
| $980K | 0.45% |
3,525
+268
| +8% | +$74.5K |
|
44
Cisco
CSCO
$268B
| $979K | 0.45% |
18,720
-342
| -2% | -$17.9K |
|
45
Walmart
WMT
$781B
| $957K | 0.44% |
6,465
-129
| -2% | -$19.1K |
|
46
Palo Alto Networks
PANW
$127B
| $940K | 0.44% |
4,706
| – | – |
|
47
International Flavors & Fragrances
IFF
$17.1B
| $933K | 0.43% |
10,061
+1,959
| +24% | +$182K |
|
48
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.09B
| $918K | 0.43% |
20,845
+1,602
| +8% | +$70.6K |
|
49
Becton Dickinson
BDX
$53.9B
| $834K | 0.39% |
3,368
-427
| -11% | -$106K |
|
50
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $674K | 0.31% |
14,916
-190
| -1% | -$8.58K |
|